11.13
price up icon3.15%   0.34
pre-market  Pre-mercato:  11.10   -0.03   -0.27%
loading
Precedente Chiudi:
$10.79
Aprire:
$10.79
Volume 24 ore:
220.85K
Relative Volume:
0.67
Capitalizzazione di mercato:
$623.47M
Reddito:
$2.22M
Utile/perdita netta:
$-40.51M
Rapporto P/E:
-8.6635
EPS:
-1.2847
Flusso di cassa netto:
$-46.53M
1 W Prestazione:
+2.20%
1M Prestazione:
+4.41%
6M Prestazione:
-31.72%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$10.60
$11.32
Intervallo di 1 settimana:
Value
$10.60
$11.58
Portata 52W:
Value
$5.14
$29.46

Upstream Bio Inc Stock (UPB) Company Profile

Name
Nome
Upstream Bio Inc
Name
Telefono
781-208-2466
Name
Indirizzo
890 WINTER STREET, SUITE 200, WALTHAM
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
UPB's Discussions on Twitter

Confronta UPB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
UPB
Upstream Bio Inc
11.13 623.47M 2.22M -40.51M -46.53M -1.2847
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Upstream Bio Inc Stock (UPB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-05 Iniziato JP Morgan Overweight
2024-11-05 Iniziato Piper Sandler Overweight
2024-11-05 Iniziato TD Cowen Buy
2024-11-05 Iniziato William Blair Outperform

Upstream Bio Inc Borsa (UPB) Ultime notizie

pulisher
Jun 16, 2025

Upstream Bio, Inc.’s Verekitug: A Promising Contender in the TSLPR Antibody Space - TipRanks

Jun 16, 2025
pulisher
Jun 15, 2025

Upstream Bio Stock Gets A Boost As New Lung Inflammation Drug Shows Higher Potency - Asianet Newsable

Jun 15, 2025
pulisher
Jun 15, 2025

Upstream Bio announces presentation of data on verekitug’s TSLP receptor - TipRanks

Jun 15, 2025
pulisher
Jun 15, 2025

Translational Data Illustrate a Mechanism of Greater - GlobeNewswire

Jun 15, 2025
pulisher
Jun 15, 2025

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor - The Manila Times

Jun 15, 2025
pulisher
Jun 15, 2025

Upstream Bio Presents Pharmacology Modeling Data Supporting Verekitug's Potency over Tezepelumab at EAACI Congress - Nasdaq

Jun 15, 2025
pulisher
Jun 15, 2025

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor - GlobeNewswire Inc.

Jun 15, 2025
pulisher
Jun 15, 2025

Bank of America Corp DE Takes Position in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

Jun 15, 2025
pulisher
Jun 12, 2025

Upstream Bio Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 11, 2025

Better Energy Stock: TotalEnergies vs. Chevron - The Globe and Mail

Jun 11, 2025
pulisher
Jun 08, 2025

Upstream Bio (NASDAQ:UPB) Raised to Hold at Wall Street Zen - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Nuveen Asset Management LLC Takes Position in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Upstream Bio, Inc. to Present TSLP Receptor Targeting Data for Verekitug at EAACI Congress 2025 - Nasdaq

Jun 05, 2025
pulisher
Jun 05, 2025

Upstream Bio to Present Mechanistic Insights into - GlobeNewswire

Jun 05, 2025
pulisher
Jun 05, 2025

Breakthrough: Upstream Bio's Verekitug Demonstrates Enhanced Potency Over Current Asthma Treatments - Stock Titan

Jun 05, 2025
pulisher
Jun 04, 2025

Upstream Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - The Manila Times

Jun 04, 2025
pulisher
Jun 04, 2025

Upstream Bio to Reveal Latest Inflammatory Disease Treatment Progress at Major Goldman Sachs Conference - Stock Titan

Jun 04, 2025
pulisher
Jun 02, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases New Position in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

Deutsche Bank AG Invests $244,000 in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

Jun 02, 2025
pulisher
May 31, 2025

An Extremely Profitable Business Plans to Go Public. What Investors Need to Know. - The Globe and Mail

May 31, 2025
pulisher
May 26, 2025

Northern Trust Corp Makes New Investment in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

May 26, 2025
pulisher
May 26, 2025

Jane Street Group LLC Takes Position in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

May 26, 2025
pulisher
May 20, 2025

Upstream Bio names new chief technology officer By Investing.com - Investing.com South Africa

May 20, 2025
pulisher
May 20, 2025

Upstream Bio names new chief technology officer - Investing.com Australia

May 20, 2025
pulisher
May 20, 2025

Upstream Bio Appoints Stacy Price as Chief Technology Officer - GlobeNewswire

May 20, 2025
pulisher
May 20, 2025

Upstream Bio, Inc. Appoints Stacy Price as Chief Technology Officer to Lead Expansion of Technical Operations - Nasdaq

May 20, 2025
pulisher
May 20, 2025

Upstream Bio Strengthens Leadership Team: Former Invivyd Executive Takes CTO Role for Critical Clinical Program - Stock Titan

May 20, 2025
pulisher
May 15, 2025

Upstream Bio Leads Life Sciences IPOs With Upsized Listing - MSN

May 15, 2025
pulisher
May 14, 2025

Tower Research Capital LLC TRC Takes Position in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

May 14, 2025
pulisher
May 10, 2025

Is Upstream Bio Inc (NASDAQ: UPB) A Good Investment Now? - Stocksregister

May 10, 2025
pulisher
May 10, 2025

Wells Fargo & Company MN Invests $149,000 in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

May 10, 2025
pulisher
May 10, 2025

27,017 Shares in Upstream Bio, Inc. (NASDAQ:UPB) Acquired by Barclays PLC - Defense World

May 10, 2025
pulisher
May 09, 2025

MetLife Investment Management LLC Invests $181,000 in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

May 09, 2025
pulisher
May 09, 2025

Brokers Offer Predictions for Upstream Bio Q2 Earnings - Defense World

May 09, 2025
pulisher
May 07, 2025

Metric Analysis: Upstream Bio Inc (UPB)’s Key Ratios in the Limelight - DWinneX

May 07, 2025
pulisher
May 07, 2025

Upstream Bio Advances Verekitug in Clinical Trials - TipRanks

May 07, 2025
pulisher
May 06, 2025

Upstream Bio, Inc.: Strong Buy Rating Driven by Promising Drug Progress and Solid Financial Position - TipRanks

May 06, 2025
pulisher
May 06, 2025

Upstream Bio reports Q1 revenue $566k, consensus $326.25k - TipRanks

May 06, 2025
pulisher
May 06, 2025

Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs - GlobeNewswire

May 06, 2025
pulisher
May 06, 2025

Transpire Bio Announces R&D and Manufacturing Expansion - The Manila Times

May 06, 2025
pulisher
May 06, 2025

Upstream Bio Fast-Tracks Clinical Trials: Key Data Coming Earlier for Revolutionary Respiratory Drug - Stock Titan

May 06, 2025
pulisher
May 05, 2025

Invesco Ltd. Buys Shares of 15,602 Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

May 05, 2025
pulisher
May 02, 2025

1,734 Shares in Upstream Bio, Inc. (NASDAQ:UPB) Purchased by Legal & General Group Plc - Defense World

May 02, 2025
pulisher
May 02, 2025

Gold Price and Miners Look Less Shiny as Global Trade Tensions Begin to Ease - The Globe and Mail

May 02, 2025
pulisher
Apr 29, 2025

JPMorgan Chase & Co. Acquires Shares of 47,792 Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

Apr 29, 2025
pulisher
Apr 26, 2025

LPL Financial LLC Cuts Stake in Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF (NYSEARCA:PDN) - Defense World

Apr 26, 2025
pulisher
Apr 26, 2025

Geode Capital Management LLC Purchases New Position in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

Apr 26, 2025
pulisher
Apr 22, 2025

Upstream Bio Inc’s Banking’s 100-Day Moving Average at 11.87: Will the Stock Break Through? - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

Medical Properties Trust Inc (MPW) Stock: Navigating a Year of Volatility - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

CytomX Therapeutics Inc’s Shares Reel: -10.73% Quarterly Revenue Decline Amid 60.07M Market Cap - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

Philip Morris International Inc (PM) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Apr 22, 2025

Upstream Bio Inc Azioni (UPB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Upstream Bio Inc Azioni (UPB) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
ORBIMED ADVISORS LLC
Director
Oct 15 '24
Buy
17.00
825,000
14,025,000
4,554,873
AI Upstream LLC
10% Owner
Oct 15 '24
Buy
17.00
1,175,000
19,975,000
1,175,000
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):